Search

Christopher Peter Behme

from Jamestown, NC
Age ~67
Get Report
Also known as:
Christopher J Behme, Christopher G Behme, Christopher P Behme, Chris Peter Behme, Chris Peter Dr Behme, Christopher Peter Be, Chris G Behme, Chris J Behme, Claus Behme
Phone and address:
3392 Cherrybrook Dr, Jamestown, NC 27282
(336) 841-2074
Related to:
Michael BehmeMartin Schmidt, 60Dorothy SmithDebra PopeDenise Schmidt, 60Kristine Behme, 28
Connected to:
Christopher A Behme, 53James E Behme, 88John W Behme, 80Debra A Behmer, 60Richard D Behmer, 79Ronald L Behmke, 70Matthew J Behmlander, 44Thomas M Behmlander, 46William L Behmlander, 35Jessica Behmoiras, 42

Christopher Behme Phones & Addresses

  • 3392 Cherrybrook Dr, Jamestown, NC 27282 (336) 841-2074
  • Saginaw, MI
  • Lake Villa, IL
  • Kenosha, WI
  • Middleton, WI
  • Freeland, MI
  • Lake Villa, IL

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Christopher Behme Photo 1

Christopher Behme

View page
Location:
United States

Publications

Us Patents

Aryl And Heteroaryl Compounds And Methods To Modulate Coagulation

View page
US Patent:
7122580, Oct 17, 2006
Filed:
Aug 8, 2003
Appl. No.:
10/637900
Inventors:
Adnan M. M. Mjalli - Jamestown NC, US
Robert C. Andrews - Jamestown NC, US
Xiao-Chuan Guo - High Point NC, US
Daniel Peter Christen - High Point NC, US
Guoxiang Huang - Greensboro NC, US
Robert Rothlein - Summerfield NC, US
Sameer Tyagi - High Point NC, US
Tripura Yaramasu - Greensboro NC, US
Christopher Behme - Jamestown NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
A61K 31/245
C07C 233/87
US Classification:
514576, 562445
Abstract:
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.

Aryl And Heteroaryl Compounds, Compositions, And Methods Of Use

View page
US Patent:
7544699, Jun 9, 2009
Filed:
Aug 6, 2004
Appl. No.:
10/913168
Inventors:
Adnan M. M. Mjalli - Jamestown NC, US
Robert C. Andrews - Jamestown NC, US
Xiao-Chuan Guo - High Point NC, US
Daniel Peter Christen - Jamestown NC, US
Guoxiang Huang - Greensboro NC, US
Robert Rothlein - Summerfield NC, US
Sameer Tyagi - High Point NC, US
Tripura Yaramasu - Greensboro NC, US
Christopher Behme - Jamestown NC, US
Assignee:
Transtech Pharma, Inc. - High Point NC
International Classification:
C07D 217/00
A61K 31/47
US Classification:
514309, 546146
Abstract:
This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be useful for inhibiting the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway.

Oxadiazoanthracene Compounds For The Treatment Of Diabetes

View page
US Patent:
7727983, Jun 1, 2010
Filed:
Mar 6, 2009
Appl. No.:
12/399504
Inventors:
Adnan M. M. Mjalli - Oak Ridge NC, US
Dharma Rao Polisetti - High Point NC, US
Thomas Scott Yokum - Greensboro NC, US
Kalpathy Santhosh - Jamestown NC, US
Mustafa Guzel - Jamestown NC, US
Christopher Behme - Jamestown NC, US
Stephen Thomas Davis - Durham NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
C07D 498/02
A61K 31/5365
US Classification:
5142298, 544101
Abstract:
The present invention provides oxadiazoanthracene derivatives of the formula (I),.

Oxadiazoanthracene Compounds For The Treatment Of Diabetes

View page
US Patent:
7790714, Sep 7, 2010
Filed:
Apr 13, 2010
Appl. No.:
12/759010
Inventors:
Adnan M.M. Mjalli - Oak Ridge NC, US
Dharma Rao Polisetti - High Point NC, US
Thomas Scott Yokum - Greensboro NC, US
Kalpathy Santhosh - Jamestown NC, US
Mustafa Guzel - Jamestown NC, US
Christopher Behme - Jamestown NC, US
Stephen Thomas Davis - Durham NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
C07D 498/02
A61K 31/5365
US Classification:
5142298, 544101
Abstract:
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof,.

Oxadiazoanthracene Compounds For The Treatment Of Diabetes

View page
US Patent:
7906507, Mar 15, 2011
Filed:
Aug 3, 2010
Appl. No.:
12/849225
Inventors:
Adnan M. M. Mjalli - Oak Ridge NC, US
Dharma Rao Polisetti - High Point NC, US
Thomas Scott Yokum - Greensboro NC, US
Kalpathy Santhosh - Jamestown NC, US
Mustafa Guzel - Jamestown NC, US
Christopher Behme - Jamestown NC, US
Stephen Thomas Davis - Durham NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
C07D 498/02
A61K 31/5365
US Classification:
5142298, 544101
Abstract:
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof,.

Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof

View page
US Patent:
8383644, Feb 26, 2013
Filed:
Jun 29, 2010
Appl. No.:
12/825631
Inventors:
Adnan M. M. Mjalli - Oak Ridge NC, US
Christopher Behme - Jamestown NC, US
Daniel P. Christen - Jamestown NC, US
Devi Reddy Gohimukkula - Jamestown NC, US
Dharma Rao Polisetti - High Point NC, US
James Quada - High Point NC, US
Jennifer L. R. Freeman - Winston-Salem NC, US
Kalpathy Santhosh - Jamestown NC, US
Muralidhar Bondlela - Greensboro NC, US
Mustafa Guzel - Jamestown NC, US
Ravindra Reddy Yarragunta - Greensboro NC, US
Robert Carl Andrews - Jamestown PA, US
Stephen Thomas Davis - Durham NC, US
Thomas Scott Yokum - Greensboro NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
C07D 491/056
A61K 31/436
US Classification:
514291, 546 90
Abstract:
The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.

Oxadiazoanthracene Compounds For The Treatment Of Diabetes

View page
US Patent:
8524708, Sep 3, 2013
Filed:
Aug 31, 2010
Appl. No.:
12/872580
Inventors:
Adnan M. M. Mjalli - Oak Ridge NC, US
Dharma Rao Polisetti - High Point NC, US
Thomas Scott Yokum - Greensboro NC, US
Kalpathy Santhosh - Jamestown NC, US
Mustafa Guzel - Jamestown NC, US
Christopher Behme - Jamestown NC, US
Stephen Thomas Davis - Durham NC, US
Assignee:
TransTech Pharma, Inc. - High Point NC
International Classification:
C07D 498/02
A61K 31/5365
US Classification:
5142298, 544101
Abstract:
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof,.

Aryl And Heteroaryl Compounds And Methods To Modulate Coagulation

View page
US Patent:
20060276518, Dec 7, 2006
Filed:
Aug 7, 2006
Appl. No.:
11/500225
Inventors:
Adnan Mjalli - Jamestown NC, US
Robert Andrews - Jamestown NC, US
Xiao-Chuan Guo - High Point NC, US
Daniel Christen - High Point NC, US
Guoxiang Huang - Greensboro NC, US
Robert Rothlein - Summerfield NC, US
Sameer Tyagi - High Point NC, US
Tripura Yaramasu - Greensboro NC, US
Christopher Behme - Jamestown NC, US
International Classification:
A61K 31/44
A61K 31/40
A61K 31/18
A61K 31/16
A61K 31/175
US Classification:
514357000, 514408000, 514602000, 514592000, 514616000
Abstract:
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.
Control profile
Christopher Peter Behme from Jamestown, NC, age ~67 Get Report